Fundraising Fox

Appello Pharmaceuticals

Nashville, US · Founded 2017 · Delaware corporation · 3 known investors

appellopharma.com ↗

Appello Pharma is a biopharmaceutical company focused on drug discovery and development for neurological and metabolic diseases. The company leverages scientific expertise and infrastructure to advance novel therapeutics through preclinical and clinical development.

BiotechDigital HealthHealthtechMedical Devices

Founders & leadership

DL
Dr. LadenCo-founder
CR
Christopher RandExecutive Officer
WS
William SlatteryDirector
HF
Howie FurstDirector
VB
Vaughn BrysonDirector
JC
Joseph Cook, Jr.Director
JP
Jeff P. ConnDirector

Investors · 3

Mountain Group CapitalNashville
Relevance VenturesBrentwood · $250K – $2.5M
Deerfield Management CompanyreportedNew Yorkvia Howard Furst · board

Reported raises · per SEC filings

Form D private placements
▶$13.5MraisedJan 2022 · 9 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Vaughn BrysonDirector
  • Howard FurstDirector
  • Christopher RandExecutive Officer
  • Joseph Cook, Jr.Director
  • Brian LadenExecutive Officer, Director
  • William SlatteryDirector
  • Jeff P. ConnDirector
Offering amount
$13.5M
Amount sold
$13.5M
Minimum investment
$1
First sale
Jan 2022
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$15.5MraisedNov 2020 · 5 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Christopher RandExecutive Officer
  • William SlatteryDirector
  • Brian LadenExecutive Officer, Director
  • Howie FurstDirector
  • Vaughn BrysonDirector
  • Joseph Cook, Jr.Director
  • Jeff P. ConnDirector
Offering amount
$15.6M
Amount sold
$15.5M
Minimum investment
$1
First sale
Jun 2018
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.